Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.80
-0.04 (-0.31%)
At close: Apr 28, 2026, 4:00 PM EDT
13.05
+0.25 (1.95%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Korro Bio Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Korro Bio stock have an average target of 34.8, with a low estimate of 8.00 and a high estimate of 100. The average target predicts an increase of 171.87% from the current stock price of 12.80.
Analyst Consensus: Buy
* Price targets were last updated on Mar 13, 2026.
Analyst Ratings
The average analyst rating for Korro Bio stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 5 | 4 | 4 |
| Buy | 1 | 1 | 4 | 5 | 6 | 6 |
| Hold | 6 | 6 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +71.87% | Mar 13, 2026 |
| Raymond James | Raymond James | Hold → Buy Upgrades $23 | Hold → Buy | Upgrades | $23 | +79.69% | Mar 13, 2026 |
| Clear Street | Clear Street | Hold → Strong Buy Upgrades $10 → $18 | Hold → Strong Buy | Upgrades | $10 → $18 | +40.62% | Feb 19, 2026 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 17, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $11 → $30 | Hold → Buy | Upgrades | $11 → $30 | +134.37% | Jan 29, 2026 |
Financial Forecast
Revenue This Year
2.50M
from 6.39M
Decreased by -60.84%
Revenue Next Year
909.59K
from 2.50M
Decreased by -63.66%
EPS This Year
-6.70
from -12.48
EPS Next Year
-6.95
from -6.70
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.6M | 2.1M | ||||||
| Avg | 2.5M | 909,585 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.0% | -16.1% | ||||||
| Avg | -60.8% | -63.7% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.20 | -2.52 | ||||||
| Avg | -6.70 | -6.95 | ||||||
| Low | -14.75 | -13.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.